Neurotensin blocks certain amphetamine-induced behaviours

G. N. Ervin, L. S. Birkemo, Charles Nemeroff, A. J. Prange

Research output: Contribution to journalArticle

199 Citations (Scopus)

Abstract

Bilateral injections of either neurotensin (NT;0.3, 1 of 5 μg in 1 μl artificial CSF) or haloperidol (HA; 2.5 or 5 μg in μl 0.3% tartaric acid) into nucleus accumbens of rats markedly diminished the forward locomotion and rearing induced by d-amphetamine (AM; 2 mg per kg, IP). Neither NT nor HA affected the insomnia or sniffing component of AM arousal. Isovolumetric intra-accumbens injections of artificial CSF or the endogenous decapeptide, luteinizing hormone-releasing hormone (LHRH; 3μg), did not affect AM behaviours. Since intra-accumbens injections of NT (1μg) or HA 2.5 μg) neither altered forward locomotion or rearing observed in untreated rats placed in an open field nor a variety of reflex activities, the observed effects of NT and HA in AM-treated rats were probably not due to imparied motor function per se. In contract, NT does not produce neuroleptic-like effects when injected into nucleus caudatus; HA (5μg) neither altered forward locomotion or rearing observed in untreated rats placed in an open field nor a variety of reflex activities, the observed effects of NT and HA in AM-treated rats were probably not due to impaired motor function per se. In contrast, NT does not produce neuroleptic-like effects when injected into nucleus caudatus; HA (5μg) blocked stereotyped snifling, licking, biting and head bobbing observed after AM (5 mg per kg, IP), but NT (3 or 5μg) did not. Since NT and dopamine are present in substantial quantities in the nucleus accumbens, NT may act in the nucleus accumbens to modulate dopaminergic function.

Original languageEnglish
Pages (from-to)73-76
Number of pages4
JournalNature
Volume291
Issue number5810
StatePublished - Jan 1 1981
Externally publishedYes

Fingerprint

Neurotensin
Amphetamine
Nucleus Accumbens
Locomotion
Caudate Nucleus
Gonadotropin-Releasing Hormone
Antipsychotic Agents
Injections
Reflex
Dextroamphetamine
Sleep Initiation and Maintenance Disorders
Haloperidol
Contracts
Arousal
Dopamine
Head

ASJC Scopus subject areas

  • General

Cite this

Ervin, G. N., Birkemo, L. S., Nemeroff, C., & Prange, A. J. (1981). Neurotensin blocks certain amphetamine-induced behaviours. Nature, 291(5810), 73-76.

Neurotensin blocks certain amphetamine-induced behaviours. / Ervin, G. N.; Birkemo, L. S.; Nemeroff, Charles; Prange, A. J.

In: Nature, Vol. 291, No. 5810, 01.01.1981, p. 73-76.

Research output: Contribution to journalArticle

Ervin, GN, Birkemo, LS, Nemeroff, C & Prange, AJ 1981, 'Neurotensin blocks certain amphetamine-induced behaviours', Nature, vol. 291, no. 5810, pp. 73-76.
Ervin GN, Birkemo LS, Nemeroff C, Prange AJ. Neurotensin blocks certain amphetamine-induced behaviours. Nature. 1981 Jan 1;291(5810):73-76.
Ervin, G. N. ; Birkemo, L. S. ; Nemeroff, Charles ; Prange, A. J. / Neurotensin blocks certain amphetamine-induced behaviours. In: Nature. 1981 ; Vol. 291, No. 5810. pp. 73-76.
@article{cd02618b8aed4eaca8fbb0805d7d10c4,
title = "Neurotensin blocks certain amphetamine-induced behaviours",
abstract = "Bilateral injections of either neurotensin (NT;0.3, 1 of 5 μg in 1 μl artificial CSF) or haloperidol (HA; 2.5 or 5 μg in μl 0.3{\%} tartaric acid) into nucleus accumbens of rats markedly diminished the forward locomotion and rearing induced by d-amphetamine (AM; 2 mg per kg, IP). Neither NT nor HA affected the insomnia or sniffing component of AM arousal. Isovolumetric intra-accumbens injections of artificial CSF or the endogenous decapeptide, luteinizing hormone-releasing hormone (LHRH; 3μg), did not affect AM behaviours. Since intra-accumbens injections of NT (1μg) or HA 2.5 μg) neither altered forward locomotion or rearing observed in untreated rats placed in an open field nor a variety of reflex activities, the observed effects of NT and HA in AM-treated rats were probably not due to imparied motor function per se. In contract, NT does not produce neuroleptic-like effects when injected into nucleus caudatus; HA (5μg) neither altered forward locomotion or rearing observed in untreated rats placed in an open field nor a variety of reflex activities, the observed effects of NT and HA in AM-treated rats were probably not due to impaired motor function per se. In contrast, NT does not produce neuroleptic-like effects when injected into nucleus caudatus; HA (5μg) blocked stereotyped snifling, licking, biting and head bobbing observed after AM (5 mg per kg, IP), but NT (3 or 5μg) did not. Since NT and dopamine are present in substantial quantities in the nucleus accumbens, NT may act in the nucleus accumbens to modulate dopaminergic function.",
author = "Ervin, {G. N.} and Birkemo, {L. S.} and Charles Nemeroff and Prange, {A. J.}",
year = "1981",
month = "1",
day = "1",
language = "English",
volume = "291",
pages = "73--76",
journal = "Nature",
issn = "0028-0836",
publisher = "Nature Publishing Group",
number = "5810",

}

TY - JOUR

T1 - Neurotensin blocks certain amphetamine-induced behaviours

AU - Ervin, G. N.

AU - Birkemo, L. S.

AU - Nemeroff, Charles

AU - Prange, A. J.

PY - 1981/1/1

Y1 - 1981/1/1

N2 - Bilateral injections of either neurotensin (NT;0.3, 1 of 5 μg in 1 μl artificial CSF) or haloperidol (HA; 2.5 or 5 μg in μl 0.3% tartaric acid) into nucleus accumbens of rats markedly diminished the forward locomotion and rearing induced by d-amphetamine (AM; 2 mg per kg, IP). Neither NT nor HA affected the insomnia or sniffing component of AM arousal. Isovolumetric intra-accumbens injections of artificial CSF or the endogenous decapeptide, luteinizing hormone-releasing hormone (LHRH; 3μg), did not affect AM behaviours. Since intra-accumbens injections of NT (1μg) or HA 2.5 μg) neither altered forward locomotion or rearing observed in untreated rats placed in an open field nor a variety of reflex activities, the observed effects of NT and HA in AM-treated rats were probably not due to imparied motor function per se. In contract, NT does not produce neuroleptic-like effects when injected into nucleus caudatus; HA (5μg) neither altered forward locomotion or rearing observed in untreated rats placed in an open field nor a variety of reflex activities, the observed effects of NT and HA in AM-treated rats were probably not due to impaired motor function per se. In contrast, NT does not produce neuroleptic-like effects when injected into nucleus caudatus; HA (5μg) blocked stereotyped snifling, licking, biting and head bobbing observed after AM (5 mg per kg, IP), but NT (3 or 5μg) did not. Since NT and dopamine are present in substantial quantities in the nucleus accumbens, NT may act in the nucleus accumbens to modulate dopaminergic function.

AB - Bilateral injections of either neurotensin (NT;0.3, 1 of 5 μg in 1 μl artificial CSF) or haloperidol (HA; 2.5 or 5 μg in μl 0.3% tartaric acid) into nucleus accumbens of rats markedly diminished the forward locomotion and rearing induced by d-amphetamine (AM; 2 mg per kg, IP). Neither NT nor HA affected the insomnia or sniffing component of AM arousal. Isovolumetric intra-accumbens injections of artificial CSF or the endogenous decapeptide, luteinizing hormone-releasing hormone (LHRH; 3μg), did not affect AM behaviours. Since intra-accumbens injections of NT (1μg) or HA 2.5 μg) neither altered forward locomotion or rearing observed in untreated rats placed in an open field nor a variety of reflex activities, the observed effects of NT and HA in AM-treated rats were probably not due to imparied motor function per se. In contract, NT does not produce neuroleptic-like effects when injected into nucleus caudatus; HA (5μg) neither altered forward locomotion or rearing observed in untreated rats placed in an open field nor a variety of reflex activities, the observed effects of NT and HA in AM-treated rats were probably not due to impaired motor function per se. In contrast, NT does not produce neuroleptic-like effects when injected into nucleus caudatus; HA (5μg) blocked stereotyped snifling, licking, biting and head bobbing observed after AM (5 mg per kg, IP), but NT (3 or 5μg) did not. Since NT and dopamine are present in substantial quantities in the nucleus accumbens, NT may act in the nucleus accumbens to modulate dopaminergic function.

UR - http://www.scopus.com/inward/record.url?scp=0019471449&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0019471449&partnerID=8YFLogxK

M3 - Article

C2 - 7231526

AN - SCOPUS:0019471449

VL - 291

SP - 73

EP - 76

JO - Nature

JF - Nature

SN - 0028-0836

IS - 5810

ER -